Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer Moonshot^SM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Notice of Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status	Expiration Date	Program Official Sort descending
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-008 (R61 Clinical Trial Not Allowed)	R61	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research	RFA-CA-24-012 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research	RFA-CA-24-014 (P50 Clinical Trial Optional)	P50	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research	RFA-CA-24-013 (U01 Clinical Trial Optional)	U01	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes	PAR-22-131 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	09/08/2025	Richard Mazurchuk, Ph.D.
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research	PAR-22-099 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	05/08/2025	Richard Mazurchuk, Ph.D.
Notice of Intent to Publish a Funding Opportunity for The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research	NOT-CA-23-081 (K12 Clinical Trial Optional)	K12	Clinical Trial Optional	06/17/2024
Discovery and Development of Natural Products for Cancer Interception and Prevention	RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed)	UH3, UG3	Clinical Trial Not Allowed	06/14/2025	Altaf Mohammed, Ph.D.
Cancer Immunoprevention Network (CIP-Net) Research Projects	RFA-CA-23-029 (UG3/UH3 Clinical Trials Not Allowed)	UH3, UG3		07/04/2024	Altaf Mohammed, Ph.D.
NCI Clinical and Translational Exploratory/Developmental Studies	PAR-22-216 (R21 Clinical Trial Optional)	R21	Clinical Trial Optional	07/02/2025	Marjorie Perloff, M.D.